LATE-LIFE DEPRESSION

For those who are suffering from feelings of depression, sadness, hopelessness, memory loss, concentration difficulties, lack of energy, or loss of interest and pleasure in activities; UCLA is conducting a 12-week research study comparing levomilnacipran (FETZIMA) to placebo for treatment of geriatric depression. If you are 60 years of age or older, you may qualify. A complete psychiatric evaluation, physical exam, and one MRI scan are provided as a part of the study. All participants will be given either levomilnacipran (FETZIMA) or a placebo (an inactive substance). You will be compensated up to $350 and parking will be reimbursed. For more information, call UCLA at: (310) 267-5264 or (310) 794-9523.